HUNTINGTON NATIONAL BANK - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2016$29,000
+70.6%
3,689
+9.8%
0.00%
Q2 2015$17,000
-41.4%
3,360
-8.9%
0.00%
-100.0%
Q1 2015$29,000
+31.8%
3,6890.0%0.00%0.0%
Q4 2014$22,0003,689
+570.7%
0.00%
Q2 2011$0
-100.0%
5500.0%0.00%
Q1 2011$2,000
-50.0%
5500.0%0.00%
Q4 2010$4,0005500.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Meditor Group Ltd 1,900,000$11,106,0001.50%
Redmile Group, LLC 1,190,440$6,958,0001.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 613,560$3,586,0000.63%
Montibus Capital Management LLC 818,575$4,784,570,0000.60%
KOPP INVESTMENT ADVISORS LLC 213,752$1,249,0000.49%
PFM Health Sciences, LP 3,646,260$21,312,0000.44%
APEX CAPITAL, LLC 1,092,900$6,388,0000.44%
FIRST MANHATTAN CO. LLC. 6,141,636$46,860,0000.32%
JHL Capital Group LLC 300,000$1,755,0000.27%
Partner Investment Management, L.P. 188,732$1,103,0000.25%
View complete list of OREXIGEN THERAPEUTICS INC shareholders